drugset / Trial / NCT03603197
BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer
Phase 2
Completed
38 enrolled
Meabco A/S
Meddoc · collabNorwegian University of Life Sciences · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether BP-C1 is effective in the short-term treatment of metastatic breast cancer patients who have previously undergone at least three lines of chemotherapy.
Timeline
- Start
- 2014-06-05
- Primary completion
- 2016-08-30
- Completion
- 2016-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BP-C1 | Other / unclassified | 0.035 mg/kg | Intramuscular |